Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.23.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities    
Net income (loss) $ 1,935 $ 159
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization expense 167 153
Amortization of debt issuance costs, premium and discount 7 7
Total losses (gains) on derivative instruments, net (1,260) 525
Net cash used for settlement of derivative instruments (11) (9)
Other 6 4
Changes in operating assets and liabilities:    
Trade and other receivables, net of current expected credit losses 358 88
Trade receivables—affiliate 288 (74)
Advances to affiliate 18 (8)
Inventory 10 25
Margin deposits 35 25
Accounts payable and accrued liabilities (617) 13
Accrued liabilities—related party (2) 1
Due to affiliates (40) (20)
Deferred revenue (61) (39)
Other, net 18 (49)
Other, net—affiliate (4) (1)
Net cash provided by operating activities 847 800
Cash flows from investing activities    
Property, plant and equipment (89) (87)
Other (5) 0
Net cash used in investing activities (94) (87)
Cash flows from financing activities    
Distributions (754) (395)
Other (1) 0
Net cash used in financing activities (755) (395)
Net increase (decrease) in cash, cash equivalents and restricted cash and cash equivalents (2) 318
Cash, Cash Equivalents—beginning of period 996 974
Cash, Cash Equivalents—end of period $ 994 $ 1,292